0000921895-21-000544.txt : 20210223
0000921895-21-000544.hdr.sgml : 20210223
20210223180157
ACCESSION NUMBER: 0000921895-21-000544
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210219
FILED AS OF DATE: 20210223
DATE AS OF CHANGE: 20210223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Erdtmann Rainer M
CENTRAL INDEX KEY: 0001455767
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36866
FILM NUMBER: 21667178
MAIL ADDRESS:
STREET 1: 1073 ARLINGTON BLVD.
CITY: EL CERRITO
STATE: CA
ZIP: 94530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Summit Therapeutics Inc.
CENTRAL INDEX KEY: 0001599298
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BROADWAY
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-514-7149
MAIL ADDRESS:
STREET 1: ONE BROADWAY
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Therapeutics plc
DATE OF NAME CHANGE: 20150219
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Corp plc
DATE OF NAME CHANGE: 20140205
4
1
form412566erd_02232021.xml
OWNERSHIP DOCUMENT
X0306
4
2021-02-19
0
0001599298
Summit Therapeutics Inc.
SMMT
0001455767
Erdtmann Rainer M
C/O SUMMIT THERAPEUTICS INC.,
ONE BROADWAY, 14TH FLOOR
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (right to buy)
7.33
2021-02-19
4
A
0
25000
A
2021-12-31
2031-02-19
Common Stock
25000
252273
D
The option was granted on February 19, 2021. The shares underlying the option are scheduled to vest in full on December 31, 2021.
Not applicable.
/s/ Michael Paul Donaldson, Attorney-in-Fact
2021-02-23